Business & Regulation

Members of The Medicine Maker 2022 Power List reveal fascinating facts about themselves.

How will pharma companies navigate America’s new abortion laws?

The International Society for Cell & Gene Therapy convened in person for the first time in two years. We spoke to an attendee for an insight

In our third C+G Champions installment, we ask industry leaders in the cell and gene field about accessibility for the many

The US drug supply chain is not immune to counterfeits – but there’s a law for that. Here’s how it has been used so far.

It’s relatively simple: Follow cGMP, keep your facilities clean, keep vermin out, and don’t sell unapproved products…

An inside view of the pharmaceutical industry in China. Where has it been, where does it stand, and where is it going?

It’s been a busy time for infectious disease vaccine news in Europe.

Academia-industry collaboration doesn’t have to be difficult; we just need to appreciate one another’s differences.

What are the biggest lessons that the pharma industry has learned from the COVID-19 pandemic?